Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease.

Recs

0
Player Avatar Kvedarna (99.51) Submitted: 1/8/2013 3:12:57 AM : Underperform Start Price: $2.29 LXRX Score: +8.99

Rating fell from 2 to 1

Featured Broker Partners


Advertisement